Neuromodulation Market – [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS) & Transcranial Magnetic Stimulation (TMS)] – Forecasts to 2017

Publisher Name :
Date:16-Jan-2013
No. of pages: 193
Inquire Before Buying

Neuromodulation devices have emerged as one of the fastest growing segments of the medical device market due to high demand for minimally invasive and non–invasive treatment. With advancements in technology, neuromodulation is expected to become a promising therapeutic area and high growth industry in the next decade, as it offers symptomatic relief mainly from chronic pain, incontinence, heart failure, headache, depression, epilepsy, etc. The neuromodulation devices market includes deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, sacral nerve stimulation and others external stimulation devices such as transcranial magnetic stimulation, and transcutaneous electrical nerve stimulation (TENS).

The neuromodulation technique acts directly upon nerves or the target area where the activity of nerves is altered due to biological responses produced by electrical stimulation or drug infusion. These devices include small electrodes that are attached to the brain, the spinal cord, or peripheral nerves. These precisely placed leads are connected by means of an extension cable to a pulse generator to generate electrical stimulation. Neuromodulation can have applications in any area of the body and can treat several diseases like chronic pain, epilepsy, psychiatric disorder, movement disorder, cardiovascular disorder, genitourinary and colorectal disorder, stroke and brain injury, and gastric disorder.

The main drivers for the neuromodulation market are the rising population of aged people and age-related diseases like Alzheimer’s, epilepsy, spinal cord injury, and Parkinson’s disease. According to the International Neuromodulation Society, about 40 million to 50 million patients worldwide suffer from epilepsy, and 1.5 million people currently (2012) suffer from Parkinson disease in the U.S. The large pool of patients that suffer from depression, stroke, anxiety disorders, lower back pain, urinary incontinence, and tremor offers the neuromodulation industry opportunities to grow in the next five years. The market for treatment of tinnitus, in particular, represents an emerging application of neuromodulation. According to the American Tinnitus Association, about 50 million people currently (2012) suffer from this disease in the U.S.

This report estimates the market for six major segments, namely, spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, gastric electrical stimulation, transcranial magnetic stimulation, and others. The report also estimates the market for different neuromodulation techniques as well as geographic analysis of each segment in North America, Europe, Asia-Pacific, and Rest of the World. As technologies develop and the number of trained physician increases, the likelihood of neuromodulation being seen as life-changing treatment will increase dramatically. It is estimated that the market for neuromodulation will be shared largely by deep brain stimulation and spinal cord stimulation.

The key players in the neuromodulation devices market are Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical (U.S.), Enteromedics, Inc (U.S.), Neuropace, Inc (U.S.), Zynex, Inc (U.S.) and Neuronetics, Inc (U.S.). The emerging players in this market are Functional Neuromodulation, Ltd (U.S.), Microtransponder (U.S.), and Neurosigma, Inc (U.S.).

Scope of the Report

The research report categorizes the global neuromodulation devices market by procedure, technology, and application. These markets are broken down into segments and sub-segments, providing exhaustive value-volume analysis for 2010, 2011, and 2012 as well as forecast up to 2017. Each market is also analyzed by geography (North America, Europe, Asia-Pacific, and Rest of the World to provide in-depth information on the global scenario.

Global Neurostimulation Devices Market, by Procedure:

  • Internal Neurostimulation
    • Spinal Cord Stimulation (SCS)
      • Failed Back Surgery Syndrome
      • Chronic Pain
      • Ischemic Pain
      • Others
    • Deep Brain Stimulation (DBS)
      • Movement Disorders
        • Parkinson’s  Disease
        • Alzheimer’s Disease
        • Dystonia
        • Tourette’s Syndrome
        • Others
      • Chronic Pain
      • Depression
      • Post-Traumatic Coma
    • Sacral Nerve Stimulation (SNS)
      • Urine Incontinence
      • Fecal Incontinence
    • Vagus Nerve Stimulation (VNS)
      • Epilepsy disease
      • Heart Failure
      • Tinnitus
      • Others
    • Gastric Electrical Stimulation (GES)
      • Gastroparesis
      • Others
  • External Neurostimulation
    • Transcranial Magnetic Stimulation (TMS)
      • Depression
      • Tinnitus
      • Migraine
      • Stroke
      • Others
    • Transcutaneous Electrical Nerve Stimulation (TENS)

Global Neurostimulation Devices Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Neuromodulation Market – [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS) & Transcranial Magnetic Stimulation (TMS)] – Forecasts to 2017

Table Of Contents

1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 RESEARCH METHODOLOGY
1.4.1 MARKET SIZE
1.4.2 MARKET SHARE
1.4.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.4.4 KEY DATA POINTS FROM PRIMARY SOURCES
1.4.5 ASSUMPTIONS
1.5 STAKEHOLDERS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 MARKET DYNAMICS
3.3.1 DRIVERS
3.3.1.1 INCREASING INCIDENCE OF NEUROLOGICAL DISORDERS TO SPUR MARKET GROWTH
3.3.1.2 UNPRECEDENTED GLOBAL AGING TO FUEL MARKET GROWTH
3.3.1.3 STRONG PRODUCT PIPELINE TO PROPEL THE MARKET
3.3.1.4 EXPANDED TARGET APPLICATIONS AND NEW INDICATIONS ARE EXPECTED TO STIMULATE GROWTH OF NEUROMODULATION DEVICES
3.3.1.5 INVESTMENTS AND FUNDS – AN IMPETUS FOR MARKET GROWTH
3.4 RESTRAINTS
3.4.1.1 AN UNFAVOURABLE REIMBURSEMENT SCENARIO HINDERS MARKET GROWTH
3.4.1.2 LACK OF TRAINED PROFESSIONALS LIKELY TO HAMPER MARKET GROWTH
3.5 MARKET SHARE ANALYSIS

4 GLOBAL NEUROMODULATION MARKET (INTERNAL & EXTERNAL)
4.1 INTRODUCTION
4.2 INTERNAL STIMULATION
4.2.1 SPINAL CORD STIMULATION (SCS) MARKET
4.2.1.1 MAJOR APPLICATIONS
4.2.1.1.1 FAILED BACK SURGERY SYNDROME
4.2.1.1.2 CHRONIC PAIN
4.2.1.1.3 ISCHEMIA
4.2.2 DEEP BRAIN STIMULATION (DBS)
4.2.2.1 MAJOR APPLICATIONS
4.2.2.1.1 PARKINSON’S DISEASE
4.2.2.1.2 DYSTONIA
4.2.2.1.3 TREMOR
4.2.2.1.4 ALZHEIMER’S
4.2.3 SACRAL NERVE STIMULATION (SNS)
4.2.3.1 MAJOR APPLICATIONS
4.2.3.1.1 URINE INCONTINENCE
4.2.3.1.2 FECAL INCONTINENCE
4.2.4 VAGUS NERVE STIMULATION (VNS)
4.2.4.1 MAJOR APPLICATIONS
4.2.4.1.1 EPILEPSY
4.2.4.1.2 OTHERS
4.2.5 GASTRIC ELECTRICAL STIMULATION (GES)
4.3 EXTERNAL STIMULATION
4.3.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)
4.3.2 TRANSCRANIAL MAGNETIC STIMULATION (TMS)

5 GEOGRAPHIC ANALYSIS
5.1 INTRODUCTION
5.2 NORTH AMERICA
5.3 EUROPE
5.4 ASIA
5.5 REST OF THE WORLD

6 COMPETITIVE LANDSCAPE
6.1 INTRODUCTION
6.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, CONTRACTS & JOINT VENTURES
6.3 NEW PRODUCT LAUNCH
6.4 EXPANSION
6.5 OTHER DEVELOPMENTS
6.6 APPROVALS

7 COMPANY PROFILES (OVERVIEW, FINANCIALS, PRODUCTS & SERVICES, STRATEGY, & DEVELOPMENTS)*
7.1 ANM ADAPTIVE NEUROMODULATION GMBH
7.2 BIOCONTROL MEDICAL, LTD.
7.3 BOSTON SCIENTIFIC CORPORATION
7.4 CERBOMED GMBH
7.5 CYBERONICS, INC.
7.6 ENDOSTIM, INC.
7.7 ENTEROMEDICS, INC.
7.8 THE MAGSTIM COMPANY LIMITED
7.9 MEDTRONIC, INC.
7.10 NEURONETICS, INC.
7.11 NEUROPACE, INC.
7.12 NEUROSIGMA, INC.
7.13 NEVRO CORPORATION
7.14 RS MEDICAL
7.15 SPINAL MODULATION, INC.
7.16 ST. JUDE MEDICAL
7.17 SYNAPSE BIOMEDICAL, INC.
7.18 UROPLASTY, INC.
7.19 ZYNEX, INC.

List Of Tables

TABLE 1 GLOBAL NEUROMODULATION MARKET, BY PROCEDURE,2010 – 2017 ($MILLION)
TABLE 2 GLOBAL NEUROMODULATION MARKET, BY MODALITY,2010 – 2017 ($MILLION)
TABLE 3 SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY,2010 – 2017 ($MILLION)
TABLE 4 SPINAL CORD STIMULATION MARKET VOLUME, BY GEOGRAPHY,2010 – 2017 (NO OF UNITS)
TABLE 5 GLOBAL SPINAL CORD STIMULATION MARKET, BY APPLICATION,2010 – 2017 ($MILLION)
TABLE 6 DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY,2010 – 2017 ($MILLION)
TABLE 7 DEEP BRAIN STIMULATION MARKET VOLUME, BY GEOGRAPHY,2010-2017 (NO OF UNITS)
TABLE 8 GLOBAL DEEP BRAIN STIMULATION MARKET, BY APPLICATION,2010 – 2017 ($MILLION)
TABLE 9 SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY,2010 – 2017 ($MILLION)
TABLE 10 SACRAL NERVE STIMULATION MARKET VOLUME, BY GEOGRAPHY,2010 – 2017 (NO OF UNITS)
TABLE 11 GLOBAL SACRAL NERVE STIMULATION MARKET, BY APPLICATION,2010 – 2017 ($MILLION)
TABLE 12 VAGUS NERVE STIMULATION MARKET, BY GEOGRAPHY,2010 – 2017 ($MILLION)
TABLE 13 VAGUS NERVE STIMULATION MARKET VOLUME, BY GEOGRAPHY,2010 – 2017 (NO OF UNITS)
TABLE 14 GLOBAL VAGUS NERVE STIMULATION MARKET, BY APPLICATION,2010 – 2017 ($MILLION)
TABLE 15 GASTRIC ELECTRICAL STIMULATION MARKET, BY GEOGRAPHY,2010 – 2017 ($MILLION)
TABLE 16 GASTRIC ELECTRICAL STIMULATION MARKET VOLUME,BY GEOGRAPHY, 2010 – 2017 (NO OF UNITS)
TABLE 17 GLOBAL GASTRIC ELECTRICAL STIMULATION MARKET,BY APPLICATION, 2010-2017 ($MILLION)
TABLE 18 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET,BY GEOGRAPHY, 2010 – 2017($MILLION)
TABLE 19 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO OF UNITS)
TABLE 20 TRANSCRANIAL MAGNETIC STIMULATION MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 21 TRANSCRANIAL MAGNETIC STIMULATION MARKET VOLUME,BY GEOGRAPHY, 2010 – 2017 (NO OF UNITS)
TABLE 22 GLOBAL TRANSCRANIAL MAGNETIC STIMULATION MARKET,BY APPLICATION, 2010 – 2017 ($MILLION)
TABLE 23 NEUROMODULATION DEVICES MARKET, BY GEOGRAPHY,2010 – 2017 ($MILLION)
TABLE 24 EXTERNAL NEUROMODULATION DEVICES MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 25 INTERNAL NEUROMODULATION DEVICES MARKET, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 26 GLOBAL EXTERNAL NEUROMODULATION MARKET, BY MODALITY,2010 – 2017 ($MILLION)
TABLE 27 GLOBAL EXTERNAL NEUROMODULATION DEVICES MARKET VOLUME,BY MODALITY, 2010 – 2017 (NO OF UNITS)
TABLE 28 NORTH AMERICA: NEUROMODULATION DEVICES MARKET,BY PROCEDURE, 2010 – 2017 ($MILLION)
TABLE 29 NORTH AMERICA: INTERNAL NEUROMODULATION DEVICES MARKET, BY MODALITY, 2010 – 2017 ($MILLION)
TABLE 30 NORTH AMERICA: INTERNAL NEUROMODULATION DEVICES MARKET VOLUME, BY MODALITY, 2010 – 2017 (NO. OF UNITS)
TABLE 31 NORTH AMERICA: EXTERNAL NEUROMODULATION DEVICES MARKET, BY MODALITY, 2010 – 2017 ($MILLION)
TABLE 32 NORTH AMERICA: EXTERNAL NEUROMODULATION DEVICES MARKET VOLUME, BY MODALITY, 2010 – 2017 (NO. OF UNITS)
TABLE 33 NORTH AMERICA: SPINAL CORD STIMULATION MARKET, BY COUNTRY, 2010 – 2017 ($MILLION)
TABLE 34 NORTH AMERICA: DEEP BRAIN STIMULATION MARKET, BY COUNTRY, 2010 – 2017 ($MILLION)
TABLE 35 NORTH AMERICA: SACRAL NERVE STIMULATION, BY COUNTRY,2010 – 2017 ($MILLION)
TABLE 36 NORTH AMERICA: VAGUS NERVE STIMULATION MARKET, BY COUNTRY, 2010 – 2017 ($MILLION)
TABLE 37 NORTH AMERICA: GASTRIC ELECTRICAL STIMULATION MARKET,BY COUNTRY, 2010 – 2017 ($MILLION)
TABLE 38 NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATION MARKET, BY COUNTRY, 2010 – 2017 ($MILLION)
TABLE 39 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, BY COUNTRY, 2010 – 2017 ($MILLION)
TABLE 40 EUROPE: NEUROMODULATION DEVICES MARKET, BY PROCEDURE,2010 – 2017 ($MILLION)
TABLE 41 EUROPE: INTERNAL NEUROMODULATION DEVICES MARKET,BY MODALITY, 2010 – 2017 ($MILLION)
TABLE 42 EUROPE: INTERNAL NEUROMODULATION DEVICES MARKET VOLUME, BY MODALITY, 2010 – 2017 (NO. OF UNITS)
TABLE 43 EUROPE: EXTERNAL NEUROMODULATION DEVICES MARKET,BY MODALITY, 2010 – 2017 ($MILLION)
TABLE 44 EUROPE: EXTERNAL NEUROMODULATION DEVICES MARKET VOLUME, BY MODALITY, 2010 – 2017 (NO. OF UNITS)
TABLE 45 EUROPE: SPINAL CORD STIMULATION MARKET, BY REGION,2010 – 2017 ($MILLION)
TABLE 46 EUROPE: DEEP BRAIN STIMULATION MARKET, BY REGION,2010 – 2017 ($MILLION)
TABLE 47 EUROPE: SACRAL NERVE STIMULATION, BY REGION,2010 – 2017 ($MILLION)
TABLE 48 EUROPE: VAGUS NERVE STIMULATION MARKET, BY REGION,2010 – 2017 ($MILLION)
TABLE 49 EUROPE: GASTRIC ELECTRICAL STIMULATION MARKET, BY REGION, 2010 – 2017 ($MILLION)
TABLE 50 EUROPE: TRANSCRANIAL MAGNETIC STIMULATION MARKET,BY REGION, 2010 – 2017 ($MILLION)
TABLE 51 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, BY REGION, 2010 – 2017 ($MILLION)
TABLE 52 ASIA: NEUROMODULATION DEVICES MARKET, BY PROCEDURE,2010 – 2017 ($MILLION)
TABLE 53 ASIA: INTERNAL NEUROMODULATION DEVICES MARKET, BY MODALITY, 2010 – 2017 ($MILLION)
TABLE 54 ASIA: INTERNAL NEUROMODULATION DEVICES MARKET VOLUME,BY MODALITY, 2010 – 2017 (NO. OF UNITS)
TABLE 55 ASIA: EXTERNAL NEUROMODULATION DEVICES MARKET,BY MODALITY, 2010 – 2017 ($MILLION)
TABLE 56 ASIA: EXTERNAL NEUROMODULATION DEVICES MARKET VOLUME,BY MODALITY, 2010 – 2017 (NO. OF UNITS)
TABLE 57 ASIA: SPINAL CORD STIMULATION MARKET, BY COUNTRY,2010 – 2017 ($MILLION)
TABLE 58 ASIA: DEEP BRAIN STIMULATION MARKET, BY COUNTRY,2010 – 2017 ($MILLION)
TABLE 59 ASIA: SACRAL NERVE STIMULATION, BY COUNTRY,2010 – 2017 ($MILLION)
TABLE 60 ASIA: TRANSCRANIAL MAGNETIC STIMULATION MARKET, BY COUNTRY, 2010 – 2017 ($MILLION)
TABLE 61 ASIA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, BY COUNTRY, 2010 – 2017 ($MILLION)
TABLE 62 ROW: NEUROMODULATION DEVICES MARKET, BY PROCEDURE,2010 – 2017 ($MILLION)
TABLE 63 ROW: INTERNAL NEUROMODULATION DEVICES MARKET, BY MODALITY, 2010 – 2017 ($MILLION)
TABLE 64 ROW: INTERNAL NEUROMODULATION DEVICES MARKET VOLUME,BY MODALITY, 2010 – 2017 (NO. OF UNITS)
TABLE 65 ROW: EXTERNAL NEUROMODULATION DEVICES MARKET,BY MODALITY, 2010 – 2017 ($MILLION)
TABLE 66 ROW: EXTERNAL NEUROMODULATION DEVICES MARKET VOLUME,BY MODALITY, 2010 – 2017 (NO. OF UNITS)
TABLE 67 ROW: SPINAL CORD STIMULATION MARKET, BY REGION,2010 – 2017 ($MILLION)
TABLE 68 ROW: DEEP BRAIN STIMULATION MARKET, BY REGION,2010 – 2017 ($MILLION)
TABLE 69 ROW: SACRAL NERVE STIMULATION, BY REGION,2010 – 2017 ($MILLION)
TABLE 70 ROW: VAGUS NERVE STIMULATION MARKET, BY REGION,2010 – 2017 ($MILLION)
TABLE 71 ROW: GASTRIC ELECTRICAL STIMULATION MARKET, BY REGION,2010 – 2017 ($MILLION)
TABLE 72 ROW: TRANSCRANIAL MAGNETIC STIMULATION MARKET, BY REGION, 2010 – 2017 ($MILLION)
TABLE 73 ROW: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, BY REGION, 2010 – 2017 ($MILLION)
TABLE 74 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, CONTRACTS & JOINT VENTURES, 2010 – 2012
TABLE 75 NEW PRODUCT LAUNCH, 2010 – 2012
TABLE 76 EXPANSION, 2010 – 2012
TABLE 77 OTHER DEVELOPMENTS, 2010 – 2012
TABLE 78 APPROVALS, 2010 – 2012
TABLE 79 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 80 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 81 BOSTON SCIENTIFIC: TOTAL REVENUE, BY GEOGRAPHY,2009 – 2011 ($MILLION)
TABLE 82 CYBERONICS, INC.: TOTAL REVENUE AND R&D EXPENDITURE,2009 – 2011 ($MILLION)
TABLE 83 CYBERONICS, INC.: TOTAL REVENUE, BY GEOGRAPHY,2009 – 2011 ($MILLION)
TABLE 84 MEDTRONIC, INC.: TOTAL REVENUE AND R&D EXPENDITURE,2009 – 2011 ($MILLION)
TABLE 85 MEDTRONIC, INC: TOTAL REVENUE, BY SEGMENTS,2009 – 2011 ($MILLION)
TABLE 86 MEDTRONIC, INC.: TOTAL REVENUE, BY GEOGRAPHY,2009 – 2011 ($MILLION)
TABLE 87 ST. JUDE MEDICAL, INC: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 88 ST. JUDE MEDICAL, INC: TOTAL REVENUE, BY SEGMENTS,2009 – 2011 ($MILLION)
TABLE 89 ST. JUDE MEDICAL, INC: TOTAL REVENUE, BY GEOGRAPHY,2009 – 2011 ($MILLION)
TABLE 90 UROPLASTY, INC.: TOTAL REVENUE AND R&D EXPENDITURE,2010-2012 ($MILLION)
TABLE 91 UROPLASTY, INC.: TOTAL REVENUE, BY GEOGRAPHY,2010 – 2012 ($MILLION)
TABLE 92 ZYNEX, INC.: TOTAL REVENUE AND R&D EXPENDITURE,2009 – 2011 ($MILLION)
TABLE 93 ZYNEX, INC.: TOTAL REVENUE, BY SEGMENTS,2009 – 2011 ($MILLION)

List Of Figures

FIGURE 1 NEUROMODULATION MARKET SEGMENTATION
FIGURE 2 MARKET DYNAMICS
FIGURE 3 NEUROMODULATION MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 4 KEY GROWTH STRATEGIES, 2010 – 2012

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • U.S. Neuromodulation, Neurovascular, Neurosurgical and Monitoring Device Market
    Published: 31-Jul-2014        Price: US $6995 Onwards        Pages: 327
    This market, collectively referred to as the U.S. neurological device market, continues to present attractive growth opportunities and is projected to grow.The market for neurological devices in the U.S. includes cerebrospinal fluid (CSF) shunts, CSF external drainage systems, intracranial pressure monitoring devices, detachable coils, liquid embolics, catheters, guidewires, traditional neurovascular stents and flow diversion stents, spinal cord stimulators, vagus nerve stimulators, sacral nerve......
  • MediPoint: Neurovascular Interventions – Current and Future Players
    Published: 30-Apr-2014        Price: US $3500 Onwards        Pages: 188
    The global neurovascular interventions market is a vast, double-digit market that consists of innovative and emerging technologies. Rapid advances in the field of neurovascular interventions and development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. The neurovascular interventions market consists of four device segments including embolization, revascularization, mechanicalthrombectomy and access/support devices.The report identifies and ......
  • MediPoint: Neurovascular Interventions – US Analysis and Market Forecasts
    Published: 30-Apr-2014        Price: US $4450 Onwards        Pages: 324
    The global neurovascular interventions market is a vast, double-digit market that consists of innovative and emerging technologies. Rapid advances in the field of neurovascular interventions and development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. The neurovascular interventions market consists of four device segments including embolization, revascularization, mechanicalthrombectomy and access/support devices.GlobalData expects the neu......
  • MediPoint: Neurovascular Interventions – South America Analysis and Market Forecasts
    Published: 30-Apr-2014        Price: US $4450 Onwards        Pages: 318
    The global neurovascular interventions market is a vast, double-digit market that consists of innovative and emerging technologies. Rapid advances in the field of neurovascular interventions and development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. The neurovascular interventions market consists of four device segments including embolization, revascularization, mechanicalthrombectomy and access/support devices.The neurovascular interven......
  • MediPoint: Neurovascular Interventions – EU Analysis and Market Forecasts
    Published: 30-Apr-2014        Price: US $4450 Onwards        Pages: 350
    The global neurovascular interventions market is a vast, double-digit market that consists of innovative and emerging technologies. Rapid advances in the field of neurovascular interventions and development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. The neurovascular interventions market consists of four device segments including embolization, revascularization, mechanicalthrombectomy and access/support devices.The neurovascular interven......
  • MediPoint: Neurovascular Interventions – APAC Analysis and Market Forecasts
    Published: 30-Apr-2014        Price: US $4450 Onwards        Pages: 342
    The global neurovascular interventions market is a vast, double-digit market that consists of innovative and emerging technologies. Rapid advances in the field of neurovascular interventions and development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. The neurovascular interventions market consists of four device segments including embolization, revascularization, mechanicalthrombectomy and access/support devices.The APAC neurovascular int......
  • MediPoint: Neurovascular Interventions – Global Analysis and Market Forecasts
    Published: 2-Apr-2014        Price: US $6495 Onwards        Pages: 432
    The global neurovascular interventions market is a vast, double-digit market that consists of innovative and emerging technologies. Rapid advances in the field of neurovascular interventions and development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. The neurovascular interventions market consists of four device segments including embolization, revascularization, mechanicalthrombectomy and access/support devices.Embolization devices inclu......
  • Japanese Market for Neurovascular Devices
    Published: 1-Nov-2013        Price: US $6995 Onwards        Pages: 76
    In 2012, the Japanese market for neurological devices was valued at nearly $553 million.The Japanese market for neurological devices includes bare platinum coils, coated coils, liquid embolics, neurovascular stents, neurovascular catheters, neurovascular guidewires, deep brain stimulators, spinal cord stimulators, sacral nerve stimulators, intrathecal pumps, frame-based stereotactic systems, frameless stereotactic systems and aneurysm clips. The growth in this market will be driven by the ra......
  • Global Electrical and Magnetic Nerve Stimulation Market 2012-2016
    Published: 1-Nov-2013        Price: US $2500 Onwards        Pages: 90
    TechNavio's analysts forecast the Global Electrical and Magnetic Nerve Stimulation market to grow at a CAGR of 4.99 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in age-related neurological disorders.The Global Electrical and Magnetic Nerve Stimulation market has also been witnessing the rising preference for minimally invasive surgery. However, the availability of alternative therapy could pose a challenge to the growth of this ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs